All Publications

Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.

SARS-CoV-2 mutations affect antigen processing by the proteasome to alter CD8+ T cell responses

Wellington D. et al, (2023), Heliyon, e20076 - e20076

Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccination

Yin Z. et al, (2023), Cell Reports, 42, 112470 - 112470

T cells are ready for the fight against monkeypox.

Wellington D. and Dong T., (2022), Cell host & microbe, 30, 1653 - 1654

IFITM3 restricts virus-induced inflammatory cytokine production by limiting Nogo-B mediated TLR responses

Clement M. et al, (2022), Nature Communications, 13

An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease

Peng Y. et al, (2022), Nature Immunology, 23, 50 - 61

SARS-CoV-2 mutations affect proteasome processing to alter CD8+ T cell responses

Wellington D. et al, (2022)

The impact of viral mutations on recognition by SARS-CoV-2 specific T cells

de Silva TI. et al, (2021), iScience, 24, 103353 - 103353

Immunodominance complexity: lessons yet to be learned from dominant T cell responses to SARS-COV-2

Wellington D. et al, (2021), Current Opinion in Virology, 50, 183 - 191

Immunodominant NP105-113-B*0702 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease

Dong T. et al, (2021)

IFITM3‐specific antibody reveals IFN preferences and slow IFN induction of the antiviral factor IFITM3 in humans

Wellington D. et al, (2021), European Journal of Immunology, 51, 742 - 745

Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

Peng Y. et al, (2020), Nature Immunology, 21, 1336 - 1345

IRF5 Promotes Influenza Virus-Induced Inflammatory Responses in Human Induced Pluripotent Stem Cell-Derived Myeloid Cells and Murine Models

Forbester JL. et al, (2020), Journal of Virology, 94

IFITM3: How genetics influence influenza infection demographically

Wellington D. et al, (2019), Biomedical Journal, 42, 19 - 26

IFITM3 regulates CMV-induced TLR-mediated inflammatory cytokine production by myeloid cells and restricts viral pathogenesis

Clement M. et al, (2019), EUROPEAN JOURNAL OF IMMUNOLOGY, 49, 1054 - 1055

IFITM3 rs12252 genotype is associated with IFITM3 expression levels and immune responses

Yin Z. et al, (2019), EUROPEAN JOURNAL OF IMMUNOLOGY, 49, 1070 - 1070

Myeloid cell expression of IRF5 enhances influenza-induced inflammation

Forbester J. et al, (2019), EUROPEAN JOURNAL OF IMMUNOLOGY, 49, 68 - 68

Viral restriction by IFITM3-is it all down to expression?

Wellington D. et al, (2019), EUROPEAN JOURNAL OF IMMUNOLOGY, 49, 1019 - 1020

High Level Antibody Response to Pandemic Influenza H1N1/09 Virus Is Associated With Interferon-Induced Transmembrane Protein-3 rs12252-CC in Young Adults

Qin L. et al, (2018), Frontiers in Cellular and Infection Microbiology, 8

Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection

Makvandi-Nejad S. et al, (2018), The Journal of Infectious Diseases, 217, 257 - 262

Pathophysiology of white matter perfusion in Alzheimer’s disease and vascular dementia

Barker R. et al, (2014), Brain, 137, 1524 - 1532

Cookies on this website

All Publications